Journal of Antivirals & Antiretrovirals
Open Access

Storr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, NSW, Australia

Biography

Mohammed Eslam works at Storr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, NSW, Australia. The authors area research interests includes Infectious diseases, Virology, Medicine. He /she has authored of many research articles/books in the relevent areas.

Publications

• Research Article   
  Characterization of Hepatocellular Carcinoma Following Direct-Acting Antiviral Therapy: A Prospective Study
  Author(s): Gamal Shiha, Talal Amer, Nabiel NH Mikhail, Reham Soliman, Mohamed Elbasiony, Doaa Gad, Ayman A Hassan, Ali Bayoumi, Alaa Ibrahim and Mohammed Eslam
  
  Background and aim: Chronic Hepatitis C (CHC) remains the most common cause of Hepatocellular Carcinoma (HCC). Direct-Acting Antiviral (DAA) therapy reduce incident of HCC among HCV-infected patients, however the impact of these therapies on tumor behavior is less clear. Here, we compared the characteristics of HCC diagnosed before and after initiation of f DAA therapy in large population-based cohort. Patients and methods: In a prospective cohort of an outreached program in 73 villages across Egypt, 14,495 (91.2%) patients were treated with DAAs and followed after SVR for median of two years (12-45 months), Of those, 275 patients had HCC (166 patients before and 109 patients after the initiation of DAA therapy). Results: Patients who developed HCC after DAA had less tumor size, portal vein invasion, advanced stage accor.. View More»
  

  Abstract HTML PDF